Tesamorelin + Ipamorelin Blend Buying Guide for Researchers

Buying a tesamorelin and ipamorelin blend for research comes down to three checks, in this order. First, confirm whether the product is a genuinely co-lyophilized blend or two separate compounds packaged together. Second, confirm that identity and purity are documented per batch on a certificate of analysis you can pull up yourself, not one that arrives by email after you've paid. Third, confirm the supplier publishes its wholesale structure before you hand over business details. Both compounds are research-use-only materials and are not approved drugs. Real Peptides supplies tesamorelin and ipamorelin as individually tested single-compound vials at 99%+ HPLC purity, with publicly verifiable COAs for every batch.

What the word "blend" is actually doing on a supplier's product page

In this category, "blend" gets used loosely. Sometimes it means two peptides genuinely co-lyophilized into one vial at a stated ratio. Sometimes it means two vials bundled into a single SKU at a bundle price. Occasionally it means nothing more than a marketing label on a listing whose documentation never mentions a second compound at all. Those are three different purchases with three different verification burdens, and the product title rarely tells you which one you're looking at.

The practical problem with a true co-lyophilized blend is analytical. A single HPLC purity percentage describes the absence of impurities — it does not, on its own, tell you the ratio of the two active components or confirm that both are present at the quantities claimed. A complete document set for a combined vial should characterize each peptide individually: identity confirmation for both, purity for both, and an account of how the stated ratio was determined. If a supplier lists a blend and publishes one number with no component breakdown, that isn't a documentation gap you can shrug off. It's the whole question.

Separate single-compound vials sidestep the problem entirely. Each compound carries its own lot number, its own chromatogram, and its own batch record. For a research buyer building a catalog, that traceability usually matters more than the convenience of one fewer vial.

The compound science, stated conservatively

Tesamorelin is a synthetic analog of growth hormone-releasing hormone. Research literature describes it as interacting with GHRH receptors, and studies have examined downstream signaling in the growth hormone axis. Ipamorelin is a pentapeptide studied as a selective growth hormone secretagogue acting at the ghrelin receptor; research suggests its selectivity profile is part of why it appears so often in preclinical investigation alongside GHRH analogs.

That overlap in pathway interest is why the two compounds are frequently paired in research contexts and why the "blend" framing caught on commercially. It is not a claim about outcomes. Nothing here describes an effect in humans, and no responsible supplier should be making one for you.

Both compounds are supplied for laboratory and research use only. They are not for human consumption, not for animal administration, and not for any diagnostic or therapeutic application. If your business has questions that touch on veterinary application of any compound, those questions belong with a licensed veterinarian and are outside the scope of a research-use catalog. The same principle applies to every downstream question about your own operation: your counsel and your licensing board answer those, not your supplier.

What a batch certificate of analysis has to show before you sign a PO

A COA is the single most informative document in this transaction, and it's the one most commonly mishandled. Three failure patterns show up repeatedly in the wholesale market, and all three are worth walking away from.

The first is the unlinked COA — a document that exists but doesn't reference the lot number printed on the vial you received. Without that link, the document proves a batch was tested, not that your batch was tested. The second is the gated COA: results available on request, after purchase, or in some cases as a paid add-on. Testing you have to buy separately is a pricing decision disguised as a quality program. The third is the summary claim with no underlying data — a purity percentage in marketing copy with no chromatogram, no mass spec trace, and no analytical method stated.

A complete panel generally covers identity confirmation, purity quantification, and contamination screening. The specific analyses vary by supplier and compound class, but the ones buyers most often look for include HPLC for purity, mass spectrometry for identity, water content, and microbial and endotoxin screening. What matters less than the exact panel list is whether you can read the actual results yourself, tied to your lot, without asking anyone's permission.

How wholesale pricing, minimums, and lead times actually work

Wholesale in this category is almost always tiered. Unit cost decreases as committed volume increases, and the tier boundaries may be set by unit count per SKU, by aggregate order value, or by a rolling commitment across a period. These three structures behave very differently for a business stocking a narrow catalog versus one stocking broadly, so the first question to ask any supplier is which structure they use — not what the discount is.

Minimums work the same way. A per-SKU minimum forces depth on every compound you list; a per-order minimum lets you go wide with less exposure on any single item. Neither is inherently better, but one of them will fit how you actually sell and the other won't. Ask directly, and be skeptical of any program that won't answer until you've submitted an application. Margins, minimums, and landed cost vary widely by volume and category, and any supplier quoting you a universal number is describing marketing, not economics.

Lead time deserves the same scrutiny. Domestic fulfillment shortens the distance between an order and a shelf and removes customs variability from your planning. International sourcing can work, but it introduces timing uncertainty you'll absorb every reorder cycle. Ask about batch continuity too: whether the supplier can keep a compound in stock across consecutive orders, and what happens to your documentation trail when a lot changes. A partner who can't answer that is a partner whose stockouts become yours.

Questions to settle with your own counsel before you stock anything

This section is informational and is not legal advice. Regulatory treatment of research compounds is genuinely unsettled and varies by jurisdiction, by business model, and by how a product is described and sold. Rather than assert what is or isn't permitted, here is the set of questions to bring to a qualified attorney and, where relevant, your state licensing board.

How does your jurisdiction characterize the sale of research-use-only materials, and does that characterization change based on who the buyer is? What licensing, registration, or recordkeeping obligations attach to your specific business type? What restrictions apply to how a product may be labeled, described, or marketed — including on your website and in any written materials? If you hold a professional license, what does your board say about ancillary product sales, and has that guidance changed recently? How should your purchase and resale records be maintained, and for how long?

Get those answered in writing, by someone accountable to you, before inventory arrives. A supplier can tell you what a compound is and what testing it passed. A supplier cannot tell you what your business is permitted to do with it, and any supplier that volunteers a confident legal conclusion is doing you a disservice.

What Real Peptides does differently

Every compound in the Real Peptides catalog is manufactured to 99%+ HPLC purity and tested through a seven-panel analysis on each batch. The certificates of analysis are publicly verifiable — you can read the actual lab results for a lot yourself, before you order and after it arrives, without submitting a request or paying for access. That's the difference between a quality claim and a quality record.

On the blend question specifically: tesamorelin and ipamorelin are supplied as individually tested single-compound vials, each with its own lot number and its own batch documentation. That keeps identity, purity, and traceability unambiguous for every unit you stock, rather than folding two actives into one document that can only partially describe either.

Fulfillment is domestic, with orders shipping within five to seven days. The Wholesale Partner Program uses a three-step application: submit your business information, get reviewed for approval, and receive partner pricing. Wholesale terms are discussed openly rather than held back as leverage, and all compounds are supplied for research use only.

Moving from evaluation to application

If your business is evaluating suppliers for research peptides and the criteria above match how you buy — verifiable documentation, domestic fulfillment, transparent wholesale terms — the next step is the Wholesale Partner Program application at Real Peptides. Bring your business details, your expected volume, and the compounds you're planning to stock, and the rest of the conversation can happen with real numbers instead of estimates.

Research buyers evaluating this pathway often review Tesamorelin 10mg and Ipamorelin 10mg side by side, compare them against CJC-1295 No DAC 10mg, and browse the broader Growth Factor & Tissue Signaling Research collection to see how batch documentation is handled consistently across the catalog.